MedTrace Logo

Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for Colonoscopy

NCT01610856 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2012-06-04

No results posted yet for this study

Summary

Proper bowel cleansing prior is an essential requirement for the conduct of colonoscopy. However, due to the nature of cleansing process, the ideal bowel cleansing preparation remains elusive.

The objective of this study is to compare the efficacy, safety and tolerability of oral polyethylene glycol lavage given either as a single dose or split dose. The study will be a randomized controlled single blind two group study. The primary study outcomes will be the previously validated Ottawa bowel preparation score.

Conditions

  • Colonoscopy Preparation

Interventions

DRUG

Polyethylene Glycol

4 Litres of polyethylene glycol bowel preparation solution

DRUG

polyethylene glycol

Polyethylene glycol 4L given in two split doses of 2L each

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Alaa Rostom, MD MSc FRCPC · University of Calgary

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01610856 on ClinicalTrials.gov